BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
SLC12A1
,
Metabolism of xenobiotics
,
Lung cancer
,
Prostate
,
Neocentromeres
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CD22 protein
Summary
General Info
Curated Studies
Most Correlated Studies
Splenic B-cells (CD22+ B220+) with Sca1-HGAL knock-in
Explore Curated Studies Results
Literature
Most Relevant Literature
ADCT-602, a Novel PBD Dimer-containing Antibody-Drug Conjugate for Treating CD22-positive Hematologi…
Modulation of CD22 Protein Expression in Childhood Leukemia by Pervasive Splicing Aberrations: Impli…
Production and characterization of a camelid single domain anti-CD22 antibody conjugated to DM1.
Enhanced efficacy of CD19/CD22 bispecific CAR-T cells with EAAAK linker on B-cell malignancies.
High yield killing of lymphoma cells by anti-CD22 CAR-NK cell therapy.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Relapsed and Refractory Lymph…
A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+C…
A Phase 1 Study of CD22-CAR TCell Immunotherapy for CD22+ Leukemia and Lymphoma
A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies
A Single-center Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LCAR-L10D Cell …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ